These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 22519486)
1. Multiple transvaginal ascitic fluid aspirations improves the clinical and reproductive outcome in patients undergoing in vitro fertilisation treatment complicated by severe early ovarian hyperstimulation syndrome. Qublan HS; Al-Taani MI; Megdadi MF; Metri RM; Al-Ahmad N J Obstet Gynaecol; 2012 May; 32(4):379-82. PubMed ID: 22519486 [TBL] [Abstract][Full Text] [Related]
2. Patients with severe ovarian hyperstimulation syndrome can be managed safely with aggressive outpatient transvaginal paracentesis. Smith LP; Hacker MR; Alper MM Fertil Steril; 2009 Dec; 92(6):1953-9. PubMed ID: 18976762 [TBL] [Abstract][Full Text] [Related]
3. Follicular aspiration during the selection phase prevents severe ovarian hyperstimulation in patients with polycystic ovary syndrome who are undergoing in vitro fertilization. Zhu WJ; Li XM; Chen XM; Zhang L Eur J Obstet Gynecol Reprod Biol; 2005 Sep; 122(1):79-84. PubMed ID: 16154042 [TBL] [Abstract][Full Text] [Related]
4. Management of severe ovarian hyperstimulation syndrome by ascitic fluid aspiration and intensive intravenous fluid therapy. Aboulghar MA; Mansour RT; Serour GI; Sattar MA; Amin YM; Elattar I Obstet Gynecol; 1993 Jan; 81(1):108-11. PubMed ID: 8416442 [TBL] [Abstract][Full Text] [Related]
5. [Integral treatment of severe ovarian hyperstimulation syndrome by means of autotransfusion of ascitic fluid and intravenous infusion of albumin]. Barrón Vallejo J; Pereyra Quiñones R; Esparza Iturbide JA; Kably Ambe A Ginecol Obstet Mex; 1998 Aug; 66():347-9. PubMed ID: 9745198 [TBL] [Abstract][Full Text] [Related]
6. Early and late ovarian hyperstimulation syndrome: early pregnancy outcome and profile. Papanikolaou EG; Tournaye H; Verpoest W; Camus M; Vernaeve V; Van Steirteghem A; Devroey P Hum Reprod; 2005 Mar; 20(3):636-41. PubMed ID: 15576388 [TBL] [Abstract][Full Text] [Related]
7. Comparison of clinical characteristics between early and late patterns in hospitalized patients with ovarian hyperstimulation syndrome. Lee KH; Kim SH; Jee BC; Kim YJ; Suh CS; Kim KC; Lee WD Fertil Steril; 2010 May; 93(7):2274-80. PubMed ID: 19249755 [TBL] [Abstract][Full Text] [Related]
8. [Study on clinical effect on infertility women with polycystic ovary syndrome treated by in vitro maturation and in vitro fertilization-embryo transfer]. Yu R; Lin J; Zhao JZ; Wang PY; Xiao SQ; Zhang W Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):250-4. PubMed ID: 22781109 [TBL] [Abstract][Full Text] [Related]
9. Removal of ascites up to 7.5 liters on one occasion and 45 liters in total may be safe in patients with severe ovarian hyperstimulation syndrome. Ozgun MT; Batukan C; Oner G; Uludag S; Aygen EM; Sahin Y Gynecol Endocrinol; 2008 Nov; 24(11):656-8. PubMed ID: 19031224 [TBL] [Abstract][Full Text] [Related]
10. Obstetric outcome of women with in vitro fertilization pregnancies hospitalized for ovarian hyperstimulation syndrome: a case-control study. Courbiere B; Oborski V; Braunstein D; Desparoir A; Noizet A; Gamerre M Fertil Steril; 2011 Apr; 95(5):1629-32. PubMed ID: 21215968 [TBL] [Abstract][Full Text] [Related]
11. Continuous vaginal and bilateral thoracic fluid drainage for management of severe ovarian hyperstimulation syndrome. Ceyhan ST; Goktolga U; Karasahin E; Alanbay I; Duru NK Gynecol Endocrinol; 2008 Sep; 24(9):505-7. PubMed ID: 18958770 [TBL] [Abstract][Full Text] [Related]
13. Comparison of in vitro fertilisation success in patients with polycystic ovary syndrome and tubal factor. Nejad ES; Saedi T; Saedi S; Rashidi BH; Nekoo ZA; Jahangiri N Gynecol Endocrinol; 2011 Feb; 27(2):117-20. PubMed ID: 20636232 [TBL] [Abstract][Full Text] [Related]
14. Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome. Moon HS; Joo BS; Moon SE; Lee SK; Kim KS; Koo JS Fertil Steril; 2008 Dec; 90(6):2172-8. PubMed ID: 18439601 [TBL] [Abstract][Full Text] [Related]
15. [Association between renin activity, angiotensin II and ovarian hyperstimulation syndrome]. Fan Y; Chen G Zhonghua Fu Chan Ke Za Zhi; 2001 Nov; 36(11):647-50. PubMed ID: 11930686 [TBL] [Abstract][Full Text] [Related]
16. [Ovarian hyperstimulation syndrome--a risk of treatment for infertility]. Bangsbøll S Nord Med; 1997 Sep; 112(7):236-9. PubMed ID: 9380489 [TBL] [Abstract][Full Text] [Related]
17. Severity of ovarian hyperstimulation syndrome: its relation to number of conceptuses. Koike T; Minakami H; Araki S; Sayama M; Matsubara S; Suzuki M Int J Fertil Womens Med; 2004; 49(1):36-42. PubMed ID: 15038508 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of metformin supplementation during ovarian stimulation of lean PCOS patients undergoing in vitro fertilization. Kumbak B; Kahraman S Acta Obstet Gynecol Scand; 2009; 88(5):563-8. PubMed ID: 19306135 [TBL] [Abstract][Full Text] [Related]
19. Endocrine gland-derived vascular endothelial growth factor concentrations in follicular fluid and serum may predict ovarian hyperstimulation syndrome in women undergoing controlled ovarian hyperstimulation. Gao MZ; Zhao XM; Sun ZG; Hong Y; Zhao LW; Zhang HQ Fertil Steril; 2011 Feb; 95(2):673-8. PubMed ID: 21067720 [TBL] [Abstract][Full Text] [Related]